₹836.65
+₹1.70 (+0.20%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹7,573 Cr
P/E
35.52
ROE
8.22%
ROCE
9.59%
About Aarti Pharmalabs Ltd
Aarti Pharmalabs The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates and Xanthine Derivatives in India.
Founded
2019
CEO
Rashesh C Gogri
Employees
3,005
HQ
Mumbai, India
About Aarti Pharmalabs Ltd
Aarti Pharmalabs The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates and Xanthine Derivatives in India.
Founded:2019
CEO:Rashesh C Gogri
Employees:3,005
HQ:Mumbai, India
Finished Products
1Sale of Manufactured Products
₹3,148.14Cr2Export incentives
₹56.96Cr3Sale of Traded Products
₹42.20Cr4S
₹13.13Cr5Sales of Services
₹9.28Cr6Sale of Scrap
₹3.77CrRaw Materials
1Cost of Material Consumed
₹1,565.55Cr2Purchase of Traded Goods
₹41.19CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹946
52W Low
₹585
Volume432.82K
Avg VolumeN/A
Beta1.13
Dividend Yield0.42%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
35.52x
Valuation
P/B Ratio
3.56x
Valuation
EPS
₹23.51
Valuation
Dividend Yield
0.42%
Valuation
ROE
8.22%
Profitability
ROCE
9.59%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmacuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
41.6%
International
58.4%
Outside India58.4%
Within India41.6%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.36x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
2.8%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.